T1/st2-receptor ligand iii
CA 2282401 A1 · Owner: Human Genome Sciences, Inc. · Inventors: Gentz, Reiner L.; Ruben, Steven M.; Ni, Jian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a novel T1-R ligand III protein which is a member of the IL-1RI ligand-like family. In particular isolated nucleic acid , molecules are provided encoding the human T1-R ligand III protein. T1-R ligand III polypeptides are also provided as are vectors host cells and recombinant , methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of T1-R ligand III activity. Also provided are diagnostic methods for detecting immune system-related disorders and therapeutic methods for treating immune system-related disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.